Gt biopharma names dr. jeff miller as consulting chief medical officer

Brisbane, california, dec. 14, 2022 (globe newswire) -- gt biopharma, inc. (the “company” or “gtb”) (nasdaq: gtbp), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the company's proprietary natural killer (nk) cell engager, trike® platform, has named dr. jeff miller, renowned nk cell cancer specialist as consulting chief medical officer.

GTBP Ratings Summary

GTBP Quant Ranking